CureVac won't seek U.S. approval for first-generation Covid vaccine
August 16, 2021 at 13:06 PM EDT
The German-headquartered biotech, whose U.S. office is in Boston, will focus instead on European authorization for its Covid-19 vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|